Stem cell-derived exosomes as a potential therapy for schistosomal hepatic fibrosis in experimental animals

Bibliographic Information
Authors: Ellakany A.R.; El Baz H.; Shoheib Z.S.; Elzallat M.; Ashour D.S.; Yassen N.A.
Journal: Pathogens and Global Health
Publisher: Taylor and Francis Ltd.
Publication Date: 30 July 2023
Volume / Issue: Volume 118 / Issue 5
Pages: 429–449
ISSN: 20477724
DOI: 10.1080/20477724.2023.2240085
Scopus: View on Scopus
PubMed: 37519008
Document Type: Article
Access: All Open Access; Green Open Access
Authors and Affiliations
Ellakany A.R., Medical Parasitology Department, Faculty of Medicine, Tanta University, Tanta, Egypt; El Baz H., Immunology Department, Theodor Bilharz Research Institute, Cairo, Egypt; Shoheib Z.S., Medical Parasitology Department, Faculty of Medicine, Tanta University, Tanta, Egypt; Elzallat M., Immunology Department, Theodor Bilharz Research Institute, Cairo, Egypt; Ashour D.S., Medical Parasitology Department, Faculty of Medicine, Tanta University, Tanta, Egypt; Yassen N.A., Medical Parasitology Department, Faculty of Medicine, Tanta University, Tanta, Egypt
Abstract
Schistosomiasis is a neglected tropical disease. Egg-induced granuloma formation and tissue fibrosis are the main causes of the high morbidity and mortality of schistosomiasis. Mesenchymal stem cells (MSCs)-derived exosomes play an important role with a superior safety profile than MSCs in the treatment of liver fibrosis. Therefore, the aim of this study was to investigate the potential therapeutic effect of MSCs-derived exosomes on schistosomal hepatic fibrosis. Exosomes were isolated from bone marrow MSCs and characterized. A total of 85 mice were divided into four groups: group I (control group), group II (PZQ group) infected and treated with PZQ, group III (EXO group) infected and treated with MSCs-derived exosomes and group IV (PZQ+EXO group) infected and treated with both PZQ and MSCs-derived exosomes. Assessment of treatment efficacy was evaluated by histopathological and immunohistochemical examination of liver sections by proliferating cell nuclear antigen (PCNA) and nuclear factor-κB (NF-κB). The results showed significant reduction of the number and diameter of hepatic granulomas, hepatic fibrosis, upregulation of PCNA expression and reduction of NF-κB expression in EXO and PZQ+EXO groups as compared to other groups at all durations post infection. Additionally, more improvement was observed in PZQ+EXO group. In conclusion, MSCs-derived exosomes are a promising agent for the treatment of schistosomal hepatic fibrosis, and their combination with PZQ shows a synergistic action including antifibrotic and anti-inflammatory effects. However, further studies are required to establish their functional components and their mechanisms of action. © 2023 Informa UK Limited, trading as Taylor & Francis Group.
Keywords
beads-based flow cytometry; liver fibrosis; NF-κB; PCNA; Schistosomiasis; stem cell-derived exosomes; Animals; Disease Models, Animal; Exosomes; Female; Liver; Liver Cirrhosis; Male; Mesenchymal Stem Cells; Mice; NF-kappa B; Praziquantel; Proliferating Cell Nuclear Antigen; Treatment Outcome; cycline; immunoglobulin enhancer binding protein; animal experiment; animal model; animal tissue; apoptosis; Article; cell infiltration; cell proliferation; cell viability; chondrocyte; controlled study; exosome; histopathology; immunophenotyping; immunoreactivity; mesenchymal stem cell; mouse; MTT assay; nonhuman; photon correlation spectroscopy; protein expression; real time polymerase chain reaction; ultracentrifugation; animal; disease model; metabolism; parasitology; pathology; therapy; transplantation
Citation Information
Scopus Citations: 6
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
